| 2024-04-22 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense |
| 2024-04-09 07:00 | UU:PSTV | | News Release200 | Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus' Management Team |
| 2024-03-27 08:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference |
| 2024-03-25 08:00 | UU:PSTV | | News Release200 | Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic |
| 2024-03-11 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases |
| 2024-03-05 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights |
| 2024-02-27 08:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024 |
| 2023-12-18 07:00 | UU:PSTV | | News Release200 | Plus Updates Financial and Cash Guidance for 2024 |
| 2023-12-12 08:00 | UU:PSTV | | News Release200 | Plus Therapeutics Partners With K2bio for Development of Novel Tests for Cerebrospinal Fluid (CSF) Tumor Cell and Molecular Biomarker Analyses |
| 2023-11-29 08:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe |
| 2023-11-20 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar |
| 2023-11-15 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023 |
| 2023-11-13 09:31 | UU:PSTV | | News Release200 | Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals? |
| 2023-11-03 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases |
| 2023-11-03 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases |
| 2023-10-31 16:10 | UU:PSTV | | News Release200 | Plus Therapeutics Announces Share Repurchase Program |
| 2023-10-31 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights |
| 2023-10-25 09:22 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar |
| 2023-10-23 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on October 31, 2023 |
| 2023-10-10 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Completes Dosing in Cohort 4 of ReSPECT-LM Phase 1 Clinical Trial of Rhenium ( ‚ ¹ ¢ ¸ ¢ ¶Re) Obisbemeda in Leptomeningeal Metastases |
| 2023-10-09 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Participate in the Jones Trading Healthcare Summit and ThinkEquity Conference in October |
| 2023-09-11 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research Conference |
| 2023-09-08 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assay |
| 2023-09-05 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Initiates Part B of ReSPECT-LM Phase 1/2a Trial for Leptomeningeal Metastase |
| 2023-08-30 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference |
| 2023-08-14 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights |
| 2023-08-11 06:30 | UU:PSTV | | News Release200 | Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at the 2023 SNO/ASCO CNS Cancer Conference |
| 2023-08-08 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 14, 2023 |
| 2023-08-08 11:23 | UU:PSTV | | News Release200 | Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference |
| 2023-08-03 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference |
| 2023-07-27 16:05 | UU:PSTV | | News Release200 | Plus Therapeutics Strengthens Clinical Program with the Appointment of Pius Maliakal as Vice President of Clinical Operations |
| 2023-07-27 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the 2023 SNO/ASCO CNS Cancer Conference |
| 2023-07-13 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals Summit |
| 2023-06-29 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Reports Positive Interim Updates from Two ReSPECT ¢ „ ¢ Clinical Trials at SNMMI Annual Meeting |
| 2023-06-14 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest |
| 2023-06-08 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Announces Participation at Upcoming SNO Pediatric Conference and SNMMI Annual Meeting |
| 2023-06-01 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Provides Company Update Today |
| 2023-05-30 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Announces Topline Results from Recurrent Glioblastoma External Control Analysis at ASCO 2023 |
| 2023-05-25 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present at the 2023 Virtual June Investor Summit |
| 2023-05-16 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics Regains Compliance with Nasdaq Listing Requirements |
| 2023-05-12 07:00 | UU:PSTV | | News Release200 | Plus Therapeutics to Present in EndBrainCancer Initiative Virtual Educational Event |